US9062045, 12

ID: ALA3703949

Chembl Id: CHEMBL3703949

PubChem CID: 71534666

Max Phase: Preclinical

Molecular Formula: C24H21N7OS

Molecular Weight: 455.55

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1cc(-c2ccc3nnc(Sc4ccc5ncc(N6CC7(COC7)C6)cc5c4)n3c2)cn1

Standard InChI:  InChI=1S/C24H21N7OS/c1-29-10-18(8-26-29)16-2-5-22-27-28-23(31(22)11-16)33-20-3-4-21-17(7-20)6-19(9-25-21)30-12-24(13-30)14-32-15-24/h2-11H,12-15H2,1H3

Standard InChI Key:  GNCNEAGBGRHTAT-UHFFFAOYSA-N

Associated Targets(Human)

MET Tclin Hepatocyte growth factor receptor (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AOX1 Tchem Aldehyde oxidase (429 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Aox1 Aldehyde oxidase (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aox1 Aldehyde oxidase (45 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AOX1 Aldehyde oxidase (16 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 455.55Molecular Weight (Monoisotopic): 455.1528AlogP: 3.67#Rotatable Bonds: 4
Polar Surface Area: 73.37Molecular Species: NEUTRALHBA: 9HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.42CX LogP: 2.47CX LogD: 2.47
Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.41Np Likeness Score: -1.92

References

1.  (2015)  Triazolopyridine compounds, 
2. Manevski N, King L, Pitt WR, Lecomte F, Toselli F..  (2019)  Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery.,  62  (24): [PMID:31385704] [10.1021/acs.jmedchem.9b00875]